1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Antibody Drug Conjugate Market
2.2. Global Antibody Drug Conjugate Market, By Drug, 2024 (US$ Million)
2.3. Global Antibody Drug Conjugate Market, By Geography, 2024 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2024

3. Antibody Drug Conjugate Market: Competitive Analysis
3.1. Market Positioning of Key Antibody Drug Conjugate Market Vendors
3.2. Strategies Adopted by Antibody Drug Conjugate Market Vendors

4. Antibody Drug Conjugate Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Antibody Drug Conjugate Market Value, 2023 - 2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Technology Landscape
4.6.4. Legal Landscape
4.6.5. Social Landscape

5. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 Versus 2033
5.3. Market Segmentation
5.3.1. Kadcyla
5.3.2. Adcetris
5.3.3. Pipeline Analysis of Antibody Drug Conjugate


6. North America Antibody Drug Conjugate Market, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
6.3.Antibody Drug Conjugate Market: By Region, 2023-2033, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)

7. UK and European Union Antibody Drug Conjugate Market, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
7.3.Antibody Drug Conjugate Market: By Region, 2023-2033, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
7.3.1.5. France
7.3.1.5.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)

8. Asia Pacific Antibody Drug Conjugate Market, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
8.3.Antibody Drug Conjugate Market: By Region, 2023-2033, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
8.3.1.3. India
8.3.1.3.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)

9. Latin America Antibody Drug Conjugate Market, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
9.3.Antibody Drug Conjugate Market: By Region, 2023-2033, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)

10. Middle East and Africa Antibody Drug Conjugate Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
10.3.Antibody Drug Conjugate Market: By Region, 2023-2033, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Antibody Drug Conjugate Market: By Drug, 2023-2033, USD (Million)

11. Company Profile
11.1. Seattle Genetics, Inc. (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
11.2. F. Hoffman-La Roche
11.3. ImmunoGen, Inc.
11.4. Bayer AG
11.5. Novartis AG
11.6. Takeda Pharmaceutical Company Limited
11.7. Immunomedics, Inc.
11.8. Agensys, Inc.
11.9. Concortis Biotherapeutics
11.10. NBE-Therapeutics
11.11. Pfizer
11.12. Polytherics (An Abzena Company)
11.13. Oxford BioTherapeutics
11.14. Spirogen (MedImmune)
11.15. Others